CAPACITY OF UNITED-STATES LABS TO PROVIDE TLI IN SUPPORT OF EARLY HIV-1 INTERVENTION

被引:8
作者
VALDISERRI, RO
CROSS, GD
GERBER, AR
SCHWARTZ, RE
HEARN, TL
机构
[1] Div. of Laboratory Systems, Public Health Practice Program, Ctrs. for Disease Control, Atlanta
关键词
D O I
10.2105/AJPH.81.4.491
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We surveyed laboratories to assess their capacity to perform T-lymphocyte immunophenotyping. Of the 1026 respondents, 279 located in 41 states and the District of Columbia performed this type of testing. Most laboratories were located in hospitals, reported a low weekly test volume, and indicated that it took 6-24 weeks for flow cytometer operators to become proficient. Many laboratories appear to have the capacity to perform additional CD4+ cell testing, but training additional operators may be necessary. The paucity of laboratories performing T-lymphocyte immunophenotyping in the public sector may affect referral patterns from that setting.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 12 条
[1]  
*CTR DIS CONTR, 1990, HIV AIDS SURV REP, P1
[2]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[3]   TARGETING AIDS PREVENTION AND TREATMENT TOWARD HIV-1-INFECTED PERSONS - THE CONCEPT OF EARLY INTERVENTION [J].
FRANCIS, DP ;
ANDERSON, RE ;
GORMAN, ME ;
FENSTERSHEIB, M ;
PADIAN, NS ;
KIZER, KW ;
CONANT, MA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (18) :2572-2576
[4]   SERUM BETA-2-MICROGLOBULIN LEVEL INCREASES IN HIV-INFECTION - RELATION TO SEROCONVERSION, CD4 T-CELL FALL AND PROGNOSIS [J].
HOFMANN, B ;
WANG, YX ;
CUMBERLAND, WG ;
DETELS, R ;
BOZORGMEHRI, M ;
FAHEY, JL .
AIDS, 1990, 4 (03) :207-214
[5]  
LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63
[6]  
MCCARTHY RC, 1989, ARCH PATHOL LAB MED, V113, P658
[7]   THE RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AMONG MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
PHAIR, J ;
MUNOZ, A ;
DETELS, R ;
KASLOW, R ;
RINALDO, C ;
SAAH, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :161-165
[8]  
VALDISERRI RO, 1990, ARCH PATHOL LAB MED, V114, P263
[9]   ZIDOVUDINE IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A CONTROLLED TRIAL IN PERSONS WITH FEWER THAN 500 CD4-POSITIVE CELLS PER CUBIC MILLIMETER [J].
VOLBERDING, PA ;
LAGAKOS, SW ;
KOCH, MA ;
PETTINELLI, C ;
MYERS, MW ;
BOOTH, DK ;
BALFOUR, HH ;
REICHMAN, RC ;
BARTLETT, JA ;
HIRSCH, MS ;
MURPHY, RL ;
HARDY, WD ;
SOEIRO, R ;
FISCHL, MA ;
BARTLETT, JG ;
MERIGAN, TC ;
HYSLOP, NE ;
RICHMAN, DD ;
VALENTINE, FT ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (14) :941-949
[10]  
1990, MMWR, V39, P137